Results 151 to 160 of about 77,458 (359)

Advanced Therapeutic Approach Based on LDHs–Mimetic Oxidoreductase

open access: yesAdvanced Science, EarlyView.
Overview of Sructure, Multienzyme‐mimicking Activity and Advanced Therapeutic Approach Based on LDHs–Mimetic Oxidoreductase. Abstract Redox dysregulation is recognized as a key driver in the pathophysiology of numerous refractory diseases, contributing significantly to the progression and poor prognosis.
Kai Song   +9 more
wiley   +1 more source

VITAMIN D LEVELS IN MULTIPLE SCLEROSIS

open access: yesMalang Neurology Journal, 2019
Background : Multiple Sclerosis is a  neurologic  disease that effect  Central Nervous System(CNS).  Vitamin D is a liposoluble prohormone. It is thought that vitamin D deficiency is responsible for Lots of diseases which includes MS .
Zeynep Hulya Durmaz   +3 more
semanticscholar   +1 more source

Targeted Medical Therapies for Vascular Anomalies: A Clinical Review

open access: yesAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, EarlyView.
ABSTRACT Vascular anomalies represent a broad spectrum of disorders characterized by aberrant blood or lymphatic vessel development, which can lead to complex clinical phenotypes. Historically, vascular anomalies were classified solely on the basis of their clinical and histopathologic features.
Whitney Eng
wiley   +1 more source

Vitamin D in amyotrophic lateral sclerosis.

open access: yesFunctional Neurology, 2017
Vitamin D supplementation has been proposed as a potential treatment to delay amyotrophic lateral sclerosis (ALS) progression. The aims of this study were to compare retrospectively vitamin D blood levels in ALS patients with those in healthy subjects ...
L. Libonati   +7 more
semanticscholar   +1 more source

Epstein–Barr Virus, Lower Vitamin D, Low Sun Exposure, and HLA‐DRB1*1501 Risk Variant Share Common Epigenetic Pathways Leading to Multiple Sclerosis Onset

open access: yesAnnals of Neurology, EarlyView.
Objectives Multiple sclerosis (MS) onset risk factors include Epstein–Barr virus (EBV) indices (including host response), lower serum 25‐vitamin D (25(OH)D) levels, low sun exposure, and HLA‐DRB1*1501. The underlying molecular mechanisms are unclear. Here, we examined mediation through differential DNA methylation (DNAm) to better understand possible ...
Steve Simpson‐Yap   +37 more
wiley   +1 more source

The Epidemiology of Primary Lateral Sclerosis: Results from a Population‐Based Cohort

open access: yesAnnals of Neurology, EarlyView.
Objective In this population‐based study, we described the epidemiology of primary lateral sclerosis (PLS) in northern Italy and compared the clinical characteristics of patients with PLS to those with predominant upper motor neuron (PUMN) involvement and classic amyotrophic lateral sclerosis (ALS).
Rosario Vasta   +17 more
wiley   +1 more source

IS THERE A LINK BETWEEN A LOW LEVEL OF VITAMIN D AND MULTIPLE SCLEROSIS?

open access: yesRomanian Journal of Neurology, 2015
Multiple Sclerosis is a neurological disorder consisting in autoimmune and inflammatory manifestations. Its evolution is characterized by axonal demyelination among the central nervous system.
D. Popescu   +4 more
semanticscholar   +1 more source

Vitamin D Deficiency as a Factor Associated with Cognitive Impairment in Patients with Type 2 Diabetes Mellitus

open access: yesSiriraj Medical Journal
Objective: Vitamin D as an essential nutrient is increasingly being studied and reported to have roles in diabetes and cognitive function through its antioxidant, anti-inflammatory, and neuroprotective functions.
Valentina Tjandra Dewi   +5 more
doaj  

Nonspecific pain is a marker for hypovitaminosis D in patients undergoing evaluation for sleep disorders: a pilot study

open access: yesNature and Science of Sleep, 2013
David E McCarty,1 Aronkumar Reddy,1 Quinton Keigley,2 Paul Y Kim,1 Stephen Cohen,2 Andrew A Marino1 1Division of Sleep Medicine, Department of Neurology, Louisiana State University Health Sciences Center, 2School of Medicine, Louisiana State University ...
McCarty DE   +5 more
doaj  

Serum Otoconin-90 and Otolin-1 Concentrations in Benign Paroxysmal Positional Vertigo

open access: yesBiomolecules
Objective: The aim was to evaluate the value of otolith-associated protein otoconin-90 (OC90) and otolin-1 in the pathogenesis research and clinical treatment of benign paroxysmal positional vertigo (BPPV).
Demet Aygun   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy